Zimmer Biomet Momentum Leads to Guidance Raise

Zimmer Biomet reported 3Q22 orthopedic sales of $1.66 billion, -0.9% compared to the third quarter of 2021. At constant currency, the company grew 5% for the quarter.

Elective procedure volumes rebounded and drove a strong performance for the company's knee and hip businesses. Those gains were offset by tough comparisons in other business...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us